Nevirapine
- Product NDC
- 64380-709
- 11-digit product format
- 643800709
- Labeler code
- 64380
- Product ID
- 64380-709_e81597ed-063a-40df-8366-cf25357311c7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Nevirapine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Strides Pharma Science Limited
- Application
- ANDA078195
- Marketing category
- ANDA
- Marketing start
- 2012-05-22
- Marketing end
- 0000-00-00
- Substance
- NEVIRAPINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 64380-709-03 | 64380070903 | 60 TABLET in 1 BOTTLE, PLASTIC (64380-709-03) | 60 tablet | 2012-05-22 | 0000-00-00 | No | No | Current |